Clinical observation of acupuncture on optimizing intraoperative anesthesia to improve postoperative PONV in patients with benign breast tumor resection

Status

Active, not recruiting

Phases

Early Phase 1

Study type

Interventional

Source

ChiCTR

Registry ID

ChiCTR2300068703

Enrollment

Unknown

Registered

2023-02-27

Start date

2023-02-27

Completion date

Unknown

Last updated

2023-05-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Post-operative nausea and vomiting

Interventions

Control group:Conventional breast surgery treatment

Acupuncture anesthesia group:Preoperative and intraoperative electroacupuncture treatment

sham-acupuncture anesthesia group:Preoperative and intraoperative sham- electroacupuncture treatment

Eligibility

Sex/Gender

Female

Age

18 Years to 70 Years

Inclusion criteria

Inclusion criteria: 1.Patients diagnosed with benign breast tumor. 2.ASA (American Society of Anesthesiologists) classification I to III, elective proposed breast surgery under general anesthesia. 3.age = 18 years and = 70 years, female. 4.understood, agreed to participate in this study and signed the informed consent form.

Exclusion criteria

Exclusion criteria: 1.patients with serious heart, respiratory, liver or kidney diseases. 2.skin allergy, severe breakage or infection at the needle site. 3.dry heaving, vomiting or moderate to severe nausea, or chronic nausea or vomiting 24 h prior to anesthesia. 4.having received antiemetic treatment within 5 days prior to surgery. 5.those who require daily opioid use for any reason within 7 days prior to surgery. 6.those who are unable to cooperate with mental disorders, impaired consciousness, behavioral disorders, etc. 7.those who are expected to require placement of a gastric tube.

Design outcomes

Primary

Measure	Time frame
Sufentanil dosage;Blood pressure;Heart rate;Oxygen saturation level;Anesthesia time;Surgery time;Resuscitation time;Incidence of nausea and vomiting at different time periods;Severity of nausea and vomiting at different times of the day;Additional postoperative doses of metoclopramide;	—

Secondary

Measure	Time frame
age;Height;weight;PONV Risk Score;current perception threshold;pain equivalent current;	—

Countries

China

Contacts

Public ContactLiJing

Yueyang Hospital of Integrative Traditional Chinese Medicine and Western Medicine, Shanghai University of Traditional Chinese Medicine

1971921250@qq.com18930568565

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026